How to Buy Fischer Medical Ventures Ltd Shares?
You can easily buy the stocks/shares of Fischer Medical Ventures Ltd (FISCHER) on Tickertape or through broker platform by opening a Demat & Trading account onlineWhat is the Share Price of Fischer Medical Ventures Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of FISCHER as on 15th May 2025 is ₹854.21What is the return on Fischer Medical Ventures Ltd share?
The past returns of Fischer Medical Ventures Ltd (FISCHER) share are- Past 1 week: N/A
- Past 1 month: -74.33
- Past 3 months: 5.29
- Past 6 months: 24.96
- Past 1 year: 12.55
- Past 3 years: 1173.91
- Past 5 years: 1794.54
What is the Dividend yield % on Fischer Medical Ventures Ltd share?
The current dividend yield of Fischer Medical Ventures Ltd (FISCHER) is 0.00What is the Market Cap of Fischer Medical Ventures Ltd?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Fischer Medical Ventures Ltd (FISCHER) is ₹5503.16Cr as of 15th May 2025What is the 52 Week High and Low of Fischer Medical Ventures Ltd?
The 52-week high and low of Fischer Medical Ventures Ltd (FISCHER) is ₹919 and ₹573.60.What is the PE and PB ratio of Fischer Medical Ventures Ltd?
The P/E (price-to-earnings) and P/B (price-to-book) ratios of Fischer Medical Ventures Ltd are 3718.35 and 67.85 respectively.Which sector does Fischer Medical Ventures Ltd belong to?
Fischer Medical Ventures Ltd (FISCHER) belongs to the Utilities sector & Power Trading & Consultancy sub-sector.What are the peers or stocks similar to Fischer Medical Ventures Ltd?
The peers or stocks similar to Fischer Medical Ventures Ltd are: and many others.Can't decide whether or not to buy Fischer Medical Ventures Ltd?
Worry no more! Login to Tickertape and check out Fischer Medical Ventures Ltd (FISCHER) scorecard & all the relevant insights today5. Test Stocks FAQ What is the 52 Week High and Low of Fischer Medical Ventures Ltd?
The 52-week high and low of Fischer Medical Ventures Ltd (FISCHER) is ₹919 and ₹573.60.1. Test Stocks FAQ for Fischer Medical Ventures Ltd Shares?
You can easily buy the stocks/shares of Fischer Medical Ventures Ltd (FISCHER) on Tickertape or through broker platform by opening a Google & Trading account online3. Test Stocks FAQ What is the Share Price of Fischer Medical Ventures Ltd?
The stock prices are volatile and keep changing through the day depending upon various factors and market conditions. The Share price of FISCHER as on 15th May 2025 is ₹854.21
Fischer Medical Ventures Ltd
FISCHER Share Price
854.210.25% (+2.11)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
How to use scorecard? Learn more
FISCHER Performance & Key Metrics
FISCHER Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 4,046.44 | 67.85 | 0.00% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 20.55 | 3.02 | 1.50% |
FISCHER Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
FISCHER Company Profile
Fischer Medical Ventures Limited is primarily involved in trading laboratory chemicals and machinery. The company focuses on providing essential supplies for laboratory operations.
PE Ratio
38.74
38.74
1Y Return
5.03%
5.03%
Buy Reco %
25.00
25.00
RTNINDIA
PE Ratio
97.74
97.74
1Y Return
21.90%
21.90%
Buy Reco %
—
—
PE Ratio
5.86
5.86
1Y Return
15.35%
15.35%
Buy Reco %
100.00
100.00
PE Ratio
58.67
58.67
1Y Return
28.70%
28.70%
Buy Reco %
—
—
FISCHER Sentiment Analysis
FISCHER Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
FISCHER Stock Summary · January 2025
Company is navigating a complex landscape characterized by declining market share in deposits, challenges in meeting Priority Sector Lending (PSL) obligations, and fluctuations in current account flows. Despite these hurdles, the bank is focusing on enhancing customer engagement and service delivery to drive deposit growth, with recent monthly inflows showing a positive trend. The management emphasizes a strategic approach to maintaining profitability over aggressive expansion, particularly in light of competitive pressures and a tight liquidity environment. Efforts to improve operational efficiencies through digitization and a commitment to stable cost management are underway, alongside a proactive strategy to reduce borrowings and strengthen the balance sheet. Overall, while facing short-term challenges, the bank remains optimistic about future performance and is committed to achieving sustainable growth through strategic investments and improved customer outreach.
FISCHER Stock Growth Drivers
FISCHER Stock Growth Drivers
5Focus on Sustainable Growth
Company is prioritizing profitable growth over mere expansion, emphasizing a strategy that encourages ground-level teams
Stable Financial Metrics
The company has maintained a return on assets (ROA) of 1.9% post-merger, showcasing stability in
FISCHER Stock Challenges
FISCHER Stock Challenges
0
Hmm, looks like there are nochallenges
FISCHER Forecast
What are forecasts?
What are forecasts?
Forecasting uses historical data as inputs to make informed predictive estimates determining the direction of future trends. Price, revenue & earnings forecasts represent where the stock level, business prospects and profits are potentially expected to be at the end of the forecast period
FISCHER Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
FISCHER
FISCHER
Income
Balance Sheet
Cash Flow
Annual Normal View
FISCHER Income Statement
FISCHER Income Statement
Annual Normal View
| Financial Year | FY 2023 | FY 2024 | FY 2025 | TTM | ||||
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.18 | 21.48 | 112.19 | 112.19 | ||||
Raw Materials | 0.00 | 0.08 | 107.87 | 107.86 | ||||
| Power & Fuel Cost | 0.00 | 0.19 | ||||||
| Employee Cost | 0.05 | 0.38 | ||||||
| Selling & Administrative Expenses | 0.11 | 1.84 | ||||||
| Operating & Other expenses | 0.00 | 16.64 | ||||||
EBITDA | 0.02 | 2.35 | 4.32 | 4.33 | ||||
| Depreciation/Amortization | 0.00 | 0.18 | 1.63 | 1.64 | ||||
| PBIT | 0.02 | 2.17 | 2.69 | 2.69 | ||||
| Interest & Other Items | 0.02 | 0.07 | 0.47 | 0.48 | ||||
| PBT | 0.00 | 2.10 | 2.22 | 2.21 | ||||
| Taxes & Other Items | 0.04 | 0.27 | 0.74 | 0.85 | ||||
| Net Income | -0.04 | 1.83 | 1.48 | 1.36 | ||||
| EPS | -2.33 | 0.68 | 0.22 | 0.25 | ||||
| DPS | 0.00 | 0.00 | 0.05 | 0.00 | ||||
| Payout ratio | 0.00 | 0.00 | 0.23 | 0.00 |
FISCHER Company Updates
FISCHER Stock Peers
What are peers and why compare against them?
What are peers and why compare against them?
A stock's peers are companies which have similar business interests, operations and belong to the same industry sector. Comparing various metrics against peers can give valuable insights on whether the company's stock is over/under-valued and the company's growth outlook vs the industry as a whole
FISCHER Past Performance & Peer Comparison
FISCHER Past Performance & Peer Comparison
Comparing 3 stocks from
UtilitiesPower Trading & Consultancy
Compare valuation-basic on Screener
UtilitiesPower Trading & Consultancy
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Fischer Medical Ventures Ltd | 3,718.35 | 67.85 | 0.00% |
| Indian Energy Exchange Ltd | 38.74 | 17.10 | 1.60% |
| Rattanindia Enterprises Ltd | 97.74 | 9.76 | — |
| PTC India Ltd | 5.86 | 0.87 | 6.57% |
FISCHER Stock Price Comparison
Compare FISCHER with any stock or ETFCompare FISCHER with any stock or ETF
FISCHER
FISCHER Holdings
FISCHER Shareholdings
What are shareholdings?
What are shareholdings?
Apart from retail investors, a company’s shares are held by promoters, foreign & domestic institutions (large investors) and mutual funds. Promoters are the ship captains and control the company’s direction. Along with institutional and mutual fund holdings, a change in their holdings can indicate performance outlook for the stock
FISCHER Promoter Holdings Trend
FISCHER Promoter Holdings Trend
FISCHER Institutional Holdings Trend
FISCHER Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
FISCHER Shareholding Pattern
FISCHER Shareholding Pattern
FISCHER Shareholding History
FISCHER Shareholding History
Foreign Institutions
smallcases containing FISCHER stock
smallcases containing FISCHER stock
Looks like this stock is not in any smallcase yet.
FISCHER Events
FISCHER Events
FISCHER Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
What are dividends?
What are dividends?
Dividends are a portion of earnings that a company distributes to all its shareholders every year. Dividend return is one of the most important things to be considered while investing for long term. It’s the additional return on top of what investors earn through price appreciation
FISCHER Dividend Trend
No dividend trend available
FISCHER Dividends
FISCHER Dividends
Hmm, looks like data is unavailable here. Please come back after some timeFISCHER Stock News & Opinions
FISCHER Stock News & Opinions
Articles & Videos
Corporate
Board of Fischer Medical Ventures recommends final dividend
Fischer Medical Ventures announced that the Board of Directors of the Company at its meeting held on 28 May 2025, inter alia, have recommended the final dividend of Rs 0.05 per equity Share (i.e. 0.5%) , subject to the approval of the shareholders.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Fischer Medical Ventures consolidated net profit declines 42.08% in the March 2025 quarter
Net profit of Fischer Medical Ventures declined 42.08% to Rs 1.50 crore in the quarter ended March 2025 as against Rs 2.59 crore during the previous quarter ended March 2024. Sales rose 136.51% to Rs 49.17 crore in the quarter ended March 2025 as against Rs 20.79 crore during the previous quarter ended March 2024. For the full year,net profit declined 20.11% to Rs 1.47 crore in the year ended March 2025 as against Rs 1.84 crore during the previous year ended March 2024. Sales rose 427.65% to Rs 110.70 crore in the year ended March 2025 as against Rs 20.98 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales49.1720.79 137 110.7020.98 428 OPM %4.8812.12 -2.568.87 - PBDT2.322.93 -21 3.862.29 69 PBT1.812.75 -34 2.222.11 5 NP1.502.59 -42 1.471.84 -20 Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Corporate
Fischer Medical Ventures to conduct board meeting
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 28 May 2025.Powered by Capital Market - Live
3 weeks agoCapital Market - Live
Corporate
Fischer Medical Ventures hold board meeting
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 26 March 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Fischer Medical Ventures reports standalone net profit of Rs 0.20 crore in the December 2024 quarter
Net profit of Fischer Medical Ventures reported to Rs 0.20 crore in the quarter ended December 2024 as against net loss of Rs 0.13 crore during the previous quarter ended December 2023. There were no Sales reported in the quarter ended December 2024 and during the previous quarter ended December 2023.Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Fischer Medical Ventures announces board meeting date
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Spotlight
Fischer Medical gains as arm gets license from CDSCO to make MRI machines
Time Medical International Ventures (India) has become the first Magnetic Resonance Imaging (MRI) manufacturer in India to receive the official license to manufacture for sale or distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the CDSCO. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: EMMA - 1.5T MRI Scanner, PICA - 0.35T MRI Scanner, MICA - 1.5T MRI Scanner and QUIN - 1.5T MRI Scanner. The EMMA, MICA, and QUIN MRI systems are 1.5T MRI scanners, offering exceptional imaging resolution and precision for a wide range of clinical applications, while the PICA model is a 0.35T MRI scanner, tailored for specific diagnostic needs. These models are available for distribution across India, helping to address the growing demand for reliable and advanced medical imaging solutions. We are thrilled to be the first Make in India company to receive the CDSCO license for the manufacturing and distribution of MRI systems. This achievement demonstrates the strength and potential of India's medical device manufacturing sector. With our EMMA, PICA, MICA, and QUIN MRI systems, we are committed to providing hospitals and diagnostic centers with cutting-edge, affordable diagnostic imaging solutions,' said the Management Team of Fischer Medical Ventures. Fischer Medical Ventures has changed the nature of Business from Manufacturing of Chemicals to Trading and Manufacturing of Medical equipment including MRI machines consequent to share subscription agreement. The company reported consolidated net profit of Rs 0.29 crore in Q2 FY25 as against net loss of Rs 0.12 crore in Q1 FY25. Net sales surged 291.9% YoY to Rs 39.66 crore in the September 2024 quarter. Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Fischer Medical Ventures' arm receives CDSCO license to manufacture MRI systems
Fischer Medical Ventures announced that its wholly owned subsidiary, Time Medical International Ventures (India) has become the first indigenous MRI manufacturer in India to receive the official License to Manufacture for Sale or Distribution of Magnetic Resonance Diagnostic Devices (MRDD) from the Central Drugs Standard Control Organization (CDSCO). This achievement marks a significant milestone in the Make in India initiative, reinforcing the company''s commitment to developing high-quality, locally manufactured medical devices that meet international standards. With this new license, Time Medical will manufacture and distribute the following MRI systems, some of which are FDA and CE approved as well, ensuring compliance with global safety, quality, and regulatory standards: 'h EMMA - 1.5T MRI Scanner 'h PICA - 0.35T MRI Scanner 'h MICA - 1.5T MRI Scanner 'h QUIN - 1.5T MRI ScannerPowered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Fischer Medical Ventures to convene EGM
Fischer Medical Ventures announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 31 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Fischer Medical Ventures announces board meeting date
Fischer Medical Ventures will hold a meeting of the Board of Directors of the Company on 3 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Pledged promoter holdings is insignificant